ReviewOpen Access
P-glycoprotein Inhibition for Optimal Drug Delivery
Authors
Author Affiliations
Stamford University Bangladesh
Published InDrug Target Insights
Year2013
Citations620
Abstract
P-glycoprotein (P-gp), an efflux membrane transporter, is widely distributed throughout the body and is responsible for limiting cellular uptake and the distribution of xenobiotics and toxic substances. Hundreds of structurally diverse therapeutic agents are substrates to it and it impedes the absorption, permeability, and retention of the drugs, extruding them out of the cells. It is overexpressed in cancer cells and accountable for obstructing cell internalization of chemotherapeutic agents and for developing transporter mediated resistance by cancer cells during anti-tumor treatments. As it jeopardizes the success of drug delivery and cancer targeting, strategies are being developed to overcome P-gp mediated drug transport. This concise review represents a brief discussion on P-gp mediated drug transport and how it hinders the success…
View at Publisher
BORR does not host full-text PDFs. The button above takes you to the original publisher.